Arabic Coffee with Two Doses of Cardamom: Effects on Health Biomarkers in Healthy Women
Background: Arabic coffee is a form of boiled unfiltered coffee rich in diterpenes, components shown to raise cholesterol. Cardamom, a component of Arabic coffee, has been traditionally used for its medicinal properties. This study investigates the effects of daily consumption of Arabic coffee with two different doses of cardamom on blood pressure, lipids, heart, and liver function biomarkers. Materials and Methods: Healthy adult females (n=36) were divided in three groups. Each was given daily 500 ml Arabic coffee, either with no cardamom (3:0, Control), or with one proportion of cardamom (3:1, ACLC), or with two proportions of cardamom (3:2, ACHC) 5 days/week, for a period of 4 weeks. Fasting blood was withdrawn at baseline, and end of intervention. Serum was analyzed for lipid profile, C-reactive protein (CRP), heart, and liver enzymes. Blood pressure was measured at the beginning and end of intervention. Results: TC was elevated in ACLC group, while TC and LDL-C increased in ACHC group. GGT significantly decreased in both groups. Coffee consumption with both cardamom doses showed no differences in blood pressure, lipids, heart and liver enzymes, or CRP compared to non-cardamom Arabic coffee. Conclusion: Daily consumption of 500 ml of Arabic coffee with regular or high doses of cardamom might be a risk factor for CVD due to elevation of TC and LDL-C especially with the high cardamom dose, despite its nil effect on blood pressure and inflammation, and beneficial effect on liver GGT enzyme.
Maha M Badkook,
Randa M Shrourou,
Arabic Coffee with Two Doses of Cardamom: Effects on Health Biomarkers in Healthy Women, International Journal of Nutrition and Food Sciences.
Vol. 2, No. 6,
2013, pp. 280-286.
M.S. Butt and M.T.Sultan. "Coffee and its Consumption: Benefits and Risks", Critical Reviews in Food Science and Nutrition, vol. 51, pp.363-73, 2011
http://www.earthtrends.wri.org. (Last Accessed: 20/1/2013)
S. Masten and R Tice. "Review of Toxicological Literature". Structure, vol.632, pp. 79-81, 1999
S.H. Jee, J. He, and L.J.Appel. "Coffee consumption and serum lipids: A meta-analysis of randomized controlled clinical trials". Am J Epid., vol.153, pp.353–362, 2001
W.C.Willett, M.J. Stampfer, and J.E. Manson. "Coffee consumption and coronary heart disease in women. A ten-year follow-up". JAMA., vol. 275, pp. 458–462, 1996
A. Ascherio, S.M. Zhang, and M.A Hernan. "Prospective study of consumption an risk of Parkinson’s disease in men and women". Annals of Neurology, vol. 50, pp.56–63, 2001
A. Ascherio, E. Salazar-Martinez, and W.C Willett. "Coffee consumption and risk for type 2 diabetes mellitus". Annals Internal Medicine, vol.140, pp.1–8, 2004.
M.C. Cornelis and A. El-Sohemy. "Coffee, caffeine, and coronary heart disease". Current opinion in clinical nutrition and metabolic Car. vol.10(6), pp.745-51, 2007
S. Hamdan. "Effects of Supercritical Carbon Dioxide and Sub-critical Propane Extraction of Thyme and Cardamom on Chemical Composition, Antioxidant Capacity and Antimicrobial Properties". Central Food Research Institute, Budapest. 2008
M. Polovka and M. Suhaj. "The Effect of Irradiation and Heat Intervention on Composition and Antioxidant Properties of Culinary Herbs and Spices — A Review". Food Reviews International, vol. 26, pp.138–161, 2010
A. Acharya , I. Das, S. Singh, and T. Saha. "Chemopreventive properties of indole-3-carbinol, diindolylmethane and other constituents of cardamom against carcinogenesis". Recent Patents on food, nutrition& agriculture., vol. 2, pp.166-77, 2010
B.E. Statland and T.J. Demas. Serum caffeine half-lives. Healthy subjects vs. patients having alcoholic hepatic disease. Am J Clin Pathol. vol. 73(3), pp.390-3, 1980
N.W. Tietz. "Specimen Collection and Processing; Sources of Biological Variation", Textbook of Clinical Chemistry, W.B. Saunders, Philadelphia, PA. pp. 478- 518, 1986
L. Siekmann, F. Ceriotti, G. Ferard, T. Kanno, G. Schumann, et al. "IFCC Primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 C. Part 2 .Reference procedure for measurement of catalytic concentrations of creatine kinase [ATP: creatine N-phosphoransfera (CK), EC 184.108.40.206]" Clinical Chemistry Lab Med., vol. 40(6), pp.635-642, 2002
HU. Bergmeyer, P. Scheibe, and A.W. Wahlefeld. "Optimization of methods for aspartate aminotransferase and alanine aminotransferase". Clinical Chemistry, vol. 24(1), pp.58-73, 1978
H.U. Bergmeyer, M. Horder, and D.W. Moss. "Provisional recommendations on IFCC methods for the measurement of catalytic concentrations of enzymes. Part 3. Revised IFCC method of aspartate aminotransferase (L-Aspartate:2- oxoglutarate aminotransferase, EC 220.127.116.11.)". Clin Chem., vol. 24(4), pp. 720-721, 1977
M.B Smith. "Equivalency of Serum and Plasma Test Results on 42 Methods on Dimension Clinical Chemistry System". Dade Behring, Newark, DE. 2001
L.M. Shaw, J.H. Stromme, JL.London, and L. Theodorsen. "IFCC method for the determination of enzymes part 4 .IFCC method for gamma-glutamyl transferase [(gamma-glutamyl)-peptide; amino acid gamma-glutamyl transferase, EC 18.104.22.168]". Clinical Chimica Acta., 15F-338F, 1983.
B.T. Doumas, B.W. Perry, E.A. Sasse, et al. "Standardization in bilirubin assays: Evaluation of selected method and stability of bilirubin solution" Clin Chem., vol.19, pp.984-993, 1973
M. P. M. E. Weusten–vanderWouw, M. B. Katan, R. Viani, , A.C. Huggett, R. Liardon, P. G. Lund-Larsen, D. S. Thelle, et al. "Identity of the coffee raising factor from boiled coffee and its effects on liver function enzymes". Journal of Lipid Research. vol. 35, pp.721–733, 1994
R. Ugert, N. Esseol, G. Vander Weg , T. G. Kosmeiger-Schuil, and M.B. Katan. "Separate effects of the coffee diterpenescafestol and kahweol on serum lipids and liver transaminases". Am J Clin Nutr., vol. 65, pp. 519–524, 1997
A.A. Al-Maghrabi . "Effect of Arabian coffee on lipids, homocysteine, glutathione and liver enzymes in rat serum". Master degree thesis, King Abdulaziz University, Jeddah. 2007
L. Cai, D. Ma, Y. Zhang, Z. Liu, and P. Wang. "The effect of coffee consumption on serum lipids: a meta-analysis of randomized controlled trials". Eur J Clin Nutr. Vol. 66(8). Pp.872-7, 2012
F. Abd El-Razek and E. Sadeek. "The chemo-protective effect of Turmeric, Chili, Cloves and Cardamom on correcting iron overload-induced liver injury, oxidative stress and serum lipid profile in rat models". J Am Sci., vol. 6, pp.702-712, 2010
A.E. Mesas, L.M. Leon-Muñoz, F. Rodriguez-Artalejo, and E. Lopez-Garcia. "The effect of coffee on blood pressure and cardiovascular disease in hypertensive individuals: a systematic review and meta-analysis". Am J Clin Nutr., vol. 94, pp.1113-26, 2011.
http://labtestsonline.org/understanding/analytes/ldh/tab/test (last accessed: 20/1/2013)
Y. Wang, J. Tuomilehto, P. Jousilahti, R. Antikainen, M. Mähönen, S. Männistö, et al. "Coffee consumption and the risk of heart failure in Finnish men and women". Heart (British cardiac society), vol. 97, pp. 44 -8, 2011.
EB. Levitan, H.N. Ahmed, M.A. Mittleman, and A.Wolk . "Coffee consumption and incidence of heart failure in women". Circulation.vol. 4, pp. 414-8, 2011.
E. Lopez-Garcia, R.M. van Dam, L. Qi, and F.B. Hu. "Coffee consumption and markers of inflammation and endothelialdys function in healthy and diabetic women1–3". Am J Clin Nutr., vol. 84, pp.888-93, 2006
A.J. Onuegbu, J.M. Olisekodiaka, O.E Adebolu, A. Adesiyan, and O.E. Ayodele. "Coffee consumption could affect the activity of some liver enzymes and other biochemical parameters in healthy drinkers, Medical principles and practice". Int J Kuwait Univ., vol. 20, pp.514-8, 2011
P. Muriel and J. Arauz. "Coffee and liver diseases". Fitoterapia., vol. 81, pp. 297-305, 2010